Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects. (Record no. 16590420)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01920 a2200577 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515042722.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200611s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1554-8600 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.4161/hv.1.6.2342 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Emery, S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20061101 |
| 245 00 - TITLE STATEMENT | |
| Title | Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Human vaccines |
| Date of publication, distribution, etc. | |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 232-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | AIDS Vaccines |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-HIV Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fowlpox virus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Products, gag |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Products, pol |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genetic Vectors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Antibodies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV-1 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-gamma |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphocyte Subsets |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vaccines, Synthetic |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Viral Load |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Workman, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Puls, R L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bloch, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baker, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bodsworth, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Anderson, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crowe, S M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | French, M A H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoy, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aichelburg, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ward, L D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boyle, D B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Law, M G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kelleher, A D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cooper, D A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Human vaccines |
| Related parts | vol. 1 |
| -- | no. 6 |
| -- | p. 232-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.4161/hv.1.6.2342">https://doi.org/10.4161/hv.1.6.2342</a> |
| Public note | Available from publisher's website |
No items available.